An Entity of Type: agent, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

AIM ImmunoTech Inc. (AMEX: AIM), formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida. focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has 23 employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. The company is developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Property Value
dbo:abstract
  • AIM ImmunoTech Inc. (AMEX: AIM), formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida. focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has 23 employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. The company is developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. (en)
dbo:assets
  • 6.4584E7
dbo:industry
dbo:keyPerson
dbo:locationCity
dbo:locationCountry
dbo:product
dbo:service
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 9519252 (xsd:integer)
dbo:wikiPageLength
  • 7544 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1113589272 (xsd:integer)
dbo:wikiPageWikiLink
dbp:assets
  • 6.4584E7
dbp:assetsYear
  • 2020 (xsd:integer)
dbp:hqLocationCity
dbp:hqLocationCountry
dbp:industry
dbp:keyPeople
  • CEO Thomas K. Equels, J.D. (en)
  • CFO Ellen Lintal (en)
  • COO Peter W. Rodino III, J.D. (en)
dbp:logo
  • AIM ImmunoTech logo.png (en)
dbp:logoCaption
  • AIM ImmunoTech company logo. (en)
dbp:name
  • AIM ImmunoTech (en)
dbp:products
dbp:services
dbp:tradeName
  • AIM (en)
dbp:tradedAs
  • AMEX:AIM (en)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • AIM ImmunoTech Inc. (AMEX: AIM), formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida. focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has 23 employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. The company is developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. (en)
rdfs:label
  • AIM ImmunoTech (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • AIM ImmunoTech (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License